Polyoxidonium 12mg 10 pills

Polyoxidonium (Polioksidoniy, Azoximeri bromidum, Azoximer bromide) - tablets 12 mg has immunomodulatory effects. The preparation increases the resistance of the body against bacterial, fungal and viral infections. The basis of the mechanism of immunomodulatory effects Polyoxidonium is to increase the ability of white blood cells phagocytose microbes and stimulate initially at low rates the production of cytokines that activate the immune system, increases antibody to infectious agents.

Polyoxidonium activates phagocytes of peripheral blood and tissue macrophages, which contributes to more rapid elimination of the pathogen from the body in the presence of the infection. Furthermore, Polyoxidonium activate lymphoid cells in the regional lymph nodes, namely the B-cells that produce secretory IgA.

With sublingual application Polyoxidonium activates lymphoid cells in the nasal cavity, the Eustachian tubes, oropharynx, bronchi. Furthermore, Polyoxidonium saliva activates bactericidal properties.

When administered orally Polyoxidonium also activate lymphoid cells located in the intestinal lymph nodes.

The consequence of this is to increase the stability of the respiratory, gastrointestinal and upper respiratory tract to infectious agents.

Along with immunomodulatory effects, has expressed Polyoxidonium detoxification and antioxidant activity, has the ability to rid the body of toxins, heavy metals, inhibits lipid peroxidation. These properties are determined by the structure and nature of the high-molecular Polyoxidonium

Application Polyoxidonium on the background of secondary immunodeficient states to improve the efficiency and reduce the duration of treatment, significantly reduce the use of antibiotics, bronchodilators, corticosteroids, lengthen remission.

The drug is well tolerated, does not have mitogenic, polyclonal activity, antigenic properties, it does not have allergenic, mutagenic, embryotoxic, teratogenic and carcinogenic effects.

Testimony:

Polyoxidonium is used in adults and adolescents over 12 years for the treatment and prevention of infectious and inflammatory diseases (viral, bacterial and fungal etiologies) are not amenable to standard therapy. Polyoxidonium used both in the acute stage, and in remission:

in the treatment of:

• Acute and chronic recurrent infectious and inflammatory diseases of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear;
• Allergic disease complicated by recurrent bacterial, fungal and viral infections (including hay fever, bronchial asthma);
• Rehabilitation and often long-term (more than 4-5 times per year) ill persons;

as monotherapy:

• For the prevention of recurrent herpes infection;
• For the prevention of seasonal exacerbation of chronic foci of infection of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear;
• In immunocompromised individuals for the prevention of influenza and other acute respiratory infections in the pre-epidemic period;
• For the correction of secondary immunodeficiency, resulting from aging or exposure to adverse factors.

Suggested Use:

Polyoxidonium pills 12 mg administered orally and sublingually for 20-30 minutes before eating daily 1, 2 or 3 times a day: adults - in doses of 12 mg or 24 mg, teenagers from 12 years - at a dose of 12 mg. The method and dosing schedule determined by the physician depending on the diagnosis, severity and the severity of the process.

Recommended regimen for

Sublingual:

• When inflammation of the oropharynx (bacterial, viral and fungal origin) - 1 tablet 2 times a day every 12 hours for 10-14 days. In severe forms of herpes and fungal infections of the oral cavity - 1 tablet 3 times a day, 8 hours for 15 days.
• In chronic diseases of the paranasal sinuses and chronic otitis - 1 tablet 2 times a day every 12 hours for 5-10 days.
• In chronic tonsillitis - 1 tablet 3 times a day, 8 hours techenie10-15 days.
• In chronic diseases of the upper respiratory tract - adults: 2 tablets 2 times a day, teenagers and 1 tablet of 12 mg 2 times a day every 12 hours for 10-14 days.
• For the prevention of influenza and acute respiratory infections - immunocompromised individuals suffering from acute respiratory infections more than 4 times a year, in the pre-epidemic period, adults 2 tablets, adolescents: 1 tablet 2 times a day every 12 hours for 10-15 days.

Orally

• In chronic diseases of the upper respiratory tract - adults: 2 tablets 2 times a day, 12 hours, adolescents: 1 tablet 2 times a day every 12 hours for 10-14 days.

Packaging:

• Comes in original packaging. Item is brand new and unopened.

Storage:

• Keep away from direct sunlight.
• Keep locked and away from children.
• Store in dry place at room temperature.
• Do not exceed storage temperature higher than 25 C

Important notice - the outer box design may vary before prior notice!